Exercise may boost Well-Being in advanced colorectal cancer patients
NCT ID NCT06938971
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a structured 18-week exercise program can improve health-related quality of life in people with metastatic colorectal cancer who are starting their first round of chemotherapy. About 150 adults will be randomly assigned to either the exercise group or a control group. The goal is to see if exercise helps them feel better physically and emotionally during treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER (MCRC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre for Physical Activity Research, Copenhagen Univerisity Hospital - Rigshospitalet
RECRUITINGCopenhagen, 2100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Herlev and Gentofte Hospital
RECRUITINGHerlev, 2730, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
North Zealand University Hospital, Hillerød
RECRUITINGHillerød, 3400, Denmark
Contact Email: •••••@•••••
-
Zealand University Hospital, Roskilde
RECRUITINGRoskilde, 4000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a vitamin b derivative boost chemo for advanced colon cancer?
- Real-World study tests fruquintinib for Tough-to-Treat colorectal cancer
- New pill combo aims to tackle Hard-to-Treat colorectal cancer
- Can a targeted drug keep working after cancer progresses? new trial aims to find out
- Promising drug duo targets Hard-to-Treat HER2 cancers
- New drug combo aims to extend life in tough colorectal cancer